Inozyme Pharma, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
INZY on Nasdaq
Industry
Pharmaceutical Preparations
Location
321 Summer Street, Suite 400, Boston, Massachusetts

Insiders trading volume in the past year

Inozyme Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Longitude Capital Partners III, LLC 10%+ Owner $14.9M Apr 19, 2022
Pivotal bioVenture Partners Fund I, L.P. Director $5.61M Aug 1, 2023
Robert Hopfner Director $5.61M Jun 18, 2024
Douglas A. Treco CEO, Director $393K -$52.2K -11.7% Apr 1, 2024
Henric Bjarke Svp, Coo $376K Dec 15, 2022
Sanjay Subramanian Svp, Cfo $109K Mar 13, 2024
Matthew Winton Coo $10.6K Mar 28, 2024
Stephen J. DiPalma Interim CFO May 17, 2021
Lynne Sullivan Director Jun 18, 2024
Edward T. Mathers Director Jun 18, 2024
Reinaldo M. Diaz Director Jun 18, 2024
Martin Edwards Director Jun 18, 2024
Axel Bolte Director Jun 18, 2024
Inozyme Pharma, Inc. Director Jun 23, 2021
Sarah Bhagat Director Jun 18, 2024

Recent Insider Transactions by Companies or Individuals for Inozyme Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.